GlassScriptPhysician profile
Austin S Ferrier
NPI 1477604270
$14,550.34
in general payments reported to CMS, 2019-2025
53 companies · $2,589 in 2025
The $2,589 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,664 · 2020: $991 · 2021: $1,593 · 2022: $2,021 · 2023: $2,242 · 2024: $2,451 · 2025: $2,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,053 · Education: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,052.96 |
| Education | $228.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,828.99 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $1,072.92 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,061.77 | 2019-2024 | Xarelto |
| Pfizer INC. | $1,022.31 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $772.28 | 2019-2024 | |
| Amgen INC. | $768.83 | 2019-2025 | Repatha, Repatha |
| Corcept Therapeutics | $752.99 | 2024-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $736.65 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $613.80 | 2019-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $602.52 | 2019-2025 | Farxiga |
| Lilly USA, LLC | $444.07 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $411.46 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $388.94 | 2024-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $371.03 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.41 | 2019-2025 | Lifevest |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $285.77 | 2022-2025 | Mcot, (5044) Mcot |
| Actelion Pharmaceuticals US, INC. | $275.90 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Abbott Laboratories | $240.39 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Baxter Healthcare | $237.24 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $197.74 | 2019-2024 | Watchman, Watchman Flx |
| Heartflow, INC. | $195.88 | 2019-2025 | Ffrct |
| Esperion Therapeutics, INC. | $190.29 | 2020-2024 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $166.11 | 2019-2025 | Evkeeza |
| Amarin Pharma, INC. | $142.02 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $137.75 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $109.78 | 2024 | Arcalyst |
| Lundbeck LLC | $96.40 | 2019-2020 | |
| Irhythm Technologies, INC. | $94.32 | 2021-2023 | Zio Xt Patch |
| Cvrx, INC. | $88.22 | 2024-2025 | Barostim Neo System |
| Arbor Pharmaceuticals, INC. | $86.21 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $83.33 | 2022-2023 | Arcalyst |
| Abiomed | $73.45 | 2019-2025 | Impella |
| Glaxosmithkline, LLC. | $73.24 | 2021-2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $67.35 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $66.06 | 2023-2024 | Optimizer, Optimizer |
| Kowa Pharmaceuticals America, INC. | $58.65 | 2021-2022 | |
| Vivus LLC | $54.93 | 2019-2022 | |
| Davol INC. | $51.46 | 2021 | |
| Bridgebio Pharma, INC. | $37.82 | 2025 | Attruby |
| Hikma Pharmaceuticals USA | $37.27 | 2019-2022 | |
| Althera Pharmaceuticals LLC | $36.79 | 2021-2022 | |
| Janssen Biotech, INC. | $31.82 | 2024 | Tecvayli, Darzalex |
| United Therapeutics Corporation | $28.28 | 2023-2024 | Tyvaso |
| Acist Medical Systems, INC. | $25.52 | 2023 | |
| Atricure, INC. | $20.82 | 2024 | |
| Recor Medical INC | $19.85 | 2025 | Paradise Ultrasound Renal Denervation System |
| Incyte Corporation | $17.62 | 2023 | Jakafi |
| Daiichi Sankyo INC. | $17.00 | 2022 | |
| Intuity Medical INC | $15.72 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Xeris Pharmaceuticals, INC. | $15.68 | 2024 | Gvoke Hypopen |
| Allergan, INC. | $13.87 | 2019 | |
| Sebela Pharmaceuticals INC. | $11.82 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Ferrier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.